<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575340</url>
  </required_header>
  <id_info>
    <org_study_id>20.179/2010-0</org_study_id>
    <nct_id>NCT01575340</nct_id>
  </id_info>
  <brief_title>Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer</brief_title>
  <official_title>Markers of the Inflammatory Response (IL-1β, IL-10, IL-17A and TNF-α) in Patients With Colorectal Cancer in Chemotherapy Supplemented With Fish Oil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Santa Catarina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa e a Inovação do Estado de Santa Catarina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro de Pesquisas Oncológicas de Florianópolis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal de Santa Catarina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether supplementation 2g/day encapsulated fish oil
      modifies inflammatory markers in individuals with colorectal cancer in chemotherapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will recruit patients with newly diagnosed colorectal cancer and that has not yet
      undergone any chemotherapy treatment. Individuals that meet the inclusion criteria are
      randomized by means of a computer program on two study groups: 1) supplemented Experimental:
      receive 2g/day supplementation encapsulated fish oil for 9 weeks. 2) No intervention -
      control: not receive supplementation of fish oil or placebo. Will be assessed the effects of
      supplementation on the standard profile of cytokine production, nutritional status, and
      proportion of incorporation of these fatty acids in blood cells (mononuclear and red blood
      cells).

      Blood samples are collected before the start of first chemotherapy and nine weeks later.
      Supplementation in the experimental group also will start on the first day of chemotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in inflammatory markers</measure>
    <time_frame>two months</time_frame>
    <description>will be evaluated cytokines IL-1 beta, IL-10, IL-17A and TNF alpha, and acute phase proteins CRP and Albumin, in baseline that corresponds to the day that the patient will begin chemotherapy and the final moment, which corresponds to 9 weeks counting from the baseline in both groups (supplemented and non-supplemented)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in body composition</measure>
    <time_frame>two months</time_frame>
    <description>will estimate the percentage of body fat in each patient through the use of skinfold thickness at baseline and end to study in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in nutritional status</measure>
    <time_frame>two months</time_frame>
    <description>will be measured anthropometric measures: weight and height (baseline and end of study) for the classification of nutritional status according to BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma lipid profile</measure>
    <time_frame>two months</time_frame>
    <description>will evaluate the proportion of incorporation of omega-3 fatty acids in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessing the risk of inflammatory and nutritional complications</measure>
    <time_frame>two months</time_frame>
    <description>Will be calculated the ratio PCR / albumin, as proposed by Correa et al., 2002, using the cutoff points proposed by the same author for the classification of high, medium, decreased or no risk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>fish oil encapsuled</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive the supplementation of 2 g / day of fish oil encapsulated for 9 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without supplementation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>not will receive supplementation or encapsulated fish oil or placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fish oil encapsuled</intervention_name>
    <description>2 g/d (4 capsules of 500 mg)for 9 weeks</description>
    <arm_group_label>fish oil encapsuled</arm_group_label>
    <other_name>omega-3 encapsuled</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 19 years

          -  Histopathological diagnosis of colorectal cancer

          -  Beginning of chemotherapy in the target institution

          -  Agree to participate in the study [signature of IC]

        Exclusion Criteria:

          -  Age &lt;19 years

          -  Being in palliative care

          -  Inability to oral intake

          -  Allergic to the fish and fish products

          -  Owning with hyperlipidemia requiring drug treatment

          -  Consumption prior to the study of fish oil or supplements containing omega-3 PUFA

          -  Being in medical treatment with some nonsteroidal anti-inflammatory

          -  Have some kind of infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel C Mocellin, Master's</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de Santa Catarina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro de Pesquisas Oncológicas - CEPON</name>
      <address>
        <city>Florianópolis</city>
        <state>Santa Catatina</state>
        <zip>88034-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2011</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>September 5, 2012</last_update_submitted>
  <last_update_submitted_qc>September 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Santa Catarina</investigator_affiliation>
    <investigator_full_name>Erasmo Benicio Santos de Moraes Trindade</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>inflammatory markers</keyword>
  <keyword>colorectal cancer</keyword>
  <keyword>cytokines</keyword>
  <keyword>fish oil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

